Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Details Narrative)

v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 23, 2024
Nov. 13, 2023
Sep. 28, 2022
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Nov. 20, 2023
Nov. 19, 2023
Subsidiary, Sale of Stock [Line Items]                    
Common stock, authorized           50,000,000   50,000,000 50,000,000 40,000,000
Common stock, par value           $ 0.001   $ 0.001    
Preferred stock, shares authorized           2,000,000   2,000,000    
Preferred stock, par value           $ 0.001   $ 0.001    
Shares issued     1              
Warrant purchase     1              
Proceeds from common stock           $ 15,000,000      
Financing fees           $ 116,664 $ 62,354      
Securities Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued 15,151,514                  
Share price $ 0.99                  
Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued       15,151,514 300,000          
Common Stock [Member] | Loan and Sercurity Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued   300,000                
Private Placement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Private placement financing units, shares     2,264,650              
Proceeds from common stock $ 15,000,000.0   $ 6,600,000              
Share price     $ 2.935              
Net proceeds     $ 6,300,000              
Financing fees     $ 300,000              
Warrant exercise price per share     $ 4.215              
Warrant expires     Sep. 28, 2027              
Offering expenses $ 100,000